P-1
εo@aΈ F{εwεw@γwςw€΄υhδw
Kazuaki Monde, Faculty of Medical and Pharmaceutical
Sciences,
Kumamoto University,
Kumamoto, Japan
Gp120 V3-dependent impairment of R5 HIV-1 infectivity due to virion incorporated
CCR5
P-2 γδ@bq F{εwGCYw€Z^[ECX§δͺμ
/ Laboratory of Immunology, NIAID, NIH, Bethesda, MD, USA
Keiko Sakai, Center
for AIDS Research, Kumamoto University,
Kumamoto, Japan
/ Laboratory of Immunology, NIAID, NIH, Bethesda, MD, USA
Molecular Analysis of HIV-1-induced CD4+ T-lymphocyte cytopathicity
P-3 ς@Χγ sεwεw@γw€ΘtEξαΰΘ
Taisuke Izumi, Graduate School of Medicine, Kyoto
University, Kyoto, Japan
MDM2 promotes the ubiquitination and degradation of HIV-1 Vif
P-4 kR@Tq sεwECX€΄υaΤ€Μζ
Hiroko Kitayama, Institute for Virus Research, Kyoto
University Kyoto, Japan
HIV-1 Vpr inhibits axon formation that leads to impaired repairment of
synaptodendritic connections through induction of mitochondrial dysfunction
P-5 εΞ@^v εγεwχΆ¨a€ECX΄υ§δͺμ
Masahisa Ohishi, Research Institute for Microbial
Diseases, Osaka University, Osaka, Japan
A study of the relationship between genomic RNA dimerization and maturation
of virus particle in HIV-1
P-6 ΨΊ@Nη
F{εwεw@γwςw€΄υ§δw
Tetsuya Kimura, Faculty
of Medical and Pharmaceutical Sciences,
Kumamoto University,
Kumamoto, Japan
Correspondence between Structure and function of HIV-1 Env protein
P-7 V²@hξ F{εwεw@γwςw€΄υhδw
Keisuke Yusa,
Faculty of Medical and Pharmaceutical
Sciences,
Kumamoto University,
Kumamoto, Japan
Characterization of CCR5 dependent replication of HIV-1V3L#25
P-8 Δc@ρ
F{εwGCYw€Z^[aΤ§δͺμ
Junji Shibata, Center
for AIDS Research, Kumamoto University,
Kumamoto, Japan
The single mutation in V2 domain affects quaternary structure of trimer
gp120 and dramatically increases the sensitivity of primary human immunodeficiency
virus type 1 isolates to neutralizing antibodies.
P-9 Όc@gC F{εwGCYw€Z^[aΤ§δͺμ
Yoshitatsu Nishida,
Center for AIDS Research,
Kumamoto University,
Kumamoto, Japan
Broad neutralization against the HIV-1 subtype B panel of reference strains
by@human monoclonal antibodies established from an HIV-1infected long-term
non-progressor
P-10 ¨c@Iq F{εwGCYw€Z^[aΤ§δͺμ
Makiko Hatada, Center for AIDS Research, Kumamoto
University,
Kumamoto, Japan
HIV-1BaL mutants escaping neutralization from a potent neutralizing anti-V3
monoclonal antibody KD-247
P-11 Oͺ@Ύ F{εwεw@γwςw€ςwΆ»wͺμ
Akira Mine, Faculty
of Medical and Pharmaceutical Sciences,
Kumamoto University,
Kumamoto, Japan
Human immunodeficiency virus-induced apoptosis of human breast cancer
cells via CXCR4 is mediated by the viral envelope protein but does not
require CD4
P-12 ‘΄@η F{εwGCYw€Z^[ECX§δͺμ
Mamoru Fujiwara, Center for AIDS
Research, Kumamoto University,
Kumamoto, Japan
Different Ability of Escape Mutant-Specific Cytotoxic T Cells to Suppress
Replication of Escape Mutant and Wild-type HIV-1 in New Hosts
P-13 ¬ς@°a F{εwGCYw€Z^[ECX§δͺμ
Hirokazu Koizumi, Center
for AIDS Research, Kumamoto University,
Kumamoto, Japan
Ability of HIV-1-specific CTL to suppress HIV-1 replication and selection
of escape mutants in chronically HIV-1-infected individuals
P-14 {@ηq F{εwGCYw€Z^[ECX§δͺμ
Chihiro Motozono, Center
for AIDS Research, Kumamoto University,
Kumamoto, Japan
The capacity of antigenic peptides that dictates antiviral activity of
Cytotoxic T Lymphocytes
P-15 gx@F F{εwGCYw€Z^[\hJͺμ
Yuka Yoshidomi, Center
for AIDS Research, Kumamoto University,
Kumamoto, Japan
Interaction between Hck and HIV-1 Nef negatively regulates cell surface
expression of M-CSF receptor
P-16 ―μ@dχ §ΫγΓZ^[€@ο‘«Ύ³€
Shigeki Hoshino,
International Medical Center of Japan,
Tokyo, Japan
HIV-1 Vpr induced IL-6 production from monocytes / macrophages via IKK,
JNK and p38 pathways
P-17 υΨ@Tη §΄υΗ€@ΖuζκΊ
Yu-ya Mitsuki, AIDS Research Center, National Institute
of Infectious Diseases,
Kumamoto, Japan
Application of DsRed expressing virus for the analysis of HIV-1 transmission
from dendritic cells to T cells.
P-18 Όi YΊ F{εwεw@γwςw€Ζu―Κwͺμ
Yusuke Matsunaga,Faculty
of Medical and Pharmaceutical Sciences,
Kumamoto University,
Kumamoto, Japan
Induction of respiratory syncytial virus antigen specific CTL by utilizing
TAP1 gene disrupted allogeneic mouse ES cell-derived dendritic cells
P-19 ¬μ@zκ RεγwηΘw³Ί
Yoichi Ogawa, Faculty of medicine, University of
Yamanashi, Yamanashi, Japan
Human Langerhans cells express the functional Toll-like
receptors at protein levels
P-20 ¬Ρ@Όχ
F{εwGCYw€Z^[ECX§δͺμ
Naoki Kobayashi, Center
for AIDS Research, Kumamoto University,
Kumamoto, Japan
Induction of HLA-A2-restricted HCMV immunodominant
epitope-specific CTLs in HIV-1-infected and -uninfected individuals with
3 HLA-A*02 subtypes
P-21 Nan Zheng
F{εwGCYw€Z^[ECX§δͺμ
Nan Zheng,
Center
for AIDS Research, Kumamoto University,
Kumamoto, Japan
Characterization of CD4+ T cell Epitopes of HIV-1 Nef protein
P-22 ͺΨc@Iκ
F{εwGCYw€Z^[ECX§δͺμ
Yuichi Yagita, Center
for AIDS Research, Kumamoto University,
Kumamoto, Japan
Selection of viral mutations by Pol283-8-specific CTLs in 2 different
HLA class I restrictions
P-23 {c@κM F{εwGCYw€Z^[ECX§δͺμ
Kazutaka Honda, Center
for AIDS Research, Kumamoto University,
Kumamoto, Japan
Strong ability of HLA-C*1202-restricted cytotoxic T lymphocytes to suppress
HIV-1 replication
P-24 μ@[ΐ F{εwGCYw€Z^[ECX§δͺμ
Yuka Kawashima, Center
for AIDS Research, Kumamoto University,
Kumamoto, Japan
Control of HIV-1 replication by HIV-1-specific CTL in HLA-B*51+ long-term
non progressors
P-25 Ίz@El F{εwGCYw€Z^[ECX§δͺμ
Hayato Murakoshi, Center for AIDS Research, Kumamoto
University,
Kumamoto, Japan
Identification of HLA-B*4801-restricted HIV-1-specific CD8 T cell epitopes
by using overlap peptides
P-26 IJ@Φq
F{εwGCYw€Z^[ECX§δͺμ / §ΫγΓZ^[@GCY‘ΓE€JZ^[
Atsuko Hachiya,
Center for AIDS Research, Kumamoto University,
Kumamoto, Japan
/ AIDS Clinical Center, International
Medical Center of Japan, Tokyo, Japan
Amino acid mutation, N348I in the connection subdomain
of HIV-1 reverse transcriptase (RT), confers multi-class resistance to
nucleoside and nonnucleoside RT inhibitors
P-27 ΒΨ@w F{εwεw@γwςw€tΰΘwͺμ
Manabu Aoki, Faculty
of Medical and Pharmaceutical Sciences,
Kumamoto University,
Kumamoto, Japan
TTNTRNS: An amino acid insert near the p17/p24 Gag cleavage site associated
with resistance to protease inhibitors
P-28 Rc@Tq γΘΘεwΆΜήΏHw€
Yuko Yamada, Institute of Biomaterials and Bioengineering,
Tokyo Medical and Dental University, Tokyo, Japan
Development of chemokine receptor CXCR4 antagonists as X4-HIV entry inhibitors
P-29 Ρc@f
§ΫγΓZ^[ GCY‘ΓE€JZ^[@Υ°€J@‘ΓJΊ
Hayashida Tsunefusa, AIDS
Clinical Center, International Medical Center of Japan,
Tokyo, Japan
Analysis of CYP2B6 genetic polymorphisms related to efavirenz concentrations
in Japanese and Zambian.
P-30 l@qq §΄υΗ€GCY€Z^[
Makiko Hamatake, AIDS Research Center, National
Institute of Infectious Diseases, Tokyo, Japan
Identification of hexa-peptidic motifs that inhibit the strand transfe
activity of HIV-1 integrase pointing a molecular surface which serves
as a potent drug target
P-31 Vμ@«V F{εwεw@γwςw€tΰΘwͺμ
Masayuki Amano,
Faculty of Medical and Pharmaceutical Sciences,
Kumamoto University,
Kumamoto, Japan
A novel bis-tetrahydrofranylurethane-containing nonpeptidic protease inhibitor
(PI) GRL-98065 potent against multi-PI-resistant HIV in vitro
P-32 ±€@N F{εwεw@γwςw€tΰΘwͺμ
Yasuhiro Koh,
Faculty of Medical and Pharmaceutical
Sciences,
Kumamoto University,
Kumamoto, Japan
Potent inhibition of HIV-1 replication by novel non-peptidyl small molecule
inhibitors of protease dimerization
P-33 ί‘@FΊ F{εwGCYw€Z^[ECX§δͺμ
Takaaki Kondo, Center
for AIDS Research, Kumamoto University,
Kumamoto, Japan
Unique cytokine secretion in human memory CD8+ T cells expressing chemokine
receptor CCR4
P-34 c@δCu
F{εwGCYw€Z^[ECX§δͺμ
Hiroshi Takata,
Center for
AIDS Research, Kumamoto University,
Kumamoto, Japan
The functional analysis of subsets in human effector CD8+ T cells
P-35 ΌΨ@θe@
F{εwGCYw€Z^[ECX§δͺμ
Fumichika Matsuki, Center
for AIDS Research, Kumamoto University,
Kumamoto, Japan
Identification of human Th17 cells by using multi-color flowcytric analysis
P-36 βi@υ^q
F{εwGCYw€Z^[\hJͺμ
Sumako Iwanagai, Center
for AIDS Research, Kumamoto University,
Kumamoto, Japan
Proliferation and Differentiation of Human B Cell in NOD/Scid/Jak-3 deficient
Mice
P-37 I}[EfBXL F{εwGCYw€Z^[\hJͺμ
Omar Dessouki, Center
for AIDS Research, Kumamoto University,
Kumamoto, Japan
Characterization of a minor human NK cell sub-population, CD56dimCD16-
cells
P-38 Oc@m
F{εwεw@γwςw€΄υhδw
Yosuke
Maeda, Faculty of Medical and
Pharmaceutical Sciences,
Kumamoto University,
Kumamoto, Japan
Characterization of human T cell lines resistant to HIV-1
|